Cima L - Search Results

1

Anthracene based compounds as new L-type Ca2+ channel blockers: design, synthesis, and full biological profile.

Bova S, Saponara S, Rampa A, Gobbi S, Cima L, Fusi F, Sgaragli G, Cavalli M, de los Rios C, Striessnig J, Bisi A. Bova S, et al. Among authors: cima l. J Med Chem. 2009 Mar 12;52(5):1259-62. doi: 10.1021/jm801589x. J Med Chem. 2009. PMID: 19203272

2

Relaxant and Ca2+ channel blocking properties of norbormide on rat non-vascular smooth muscles.

Bova S, Cavalli M, Cima L, Luciani S, Saponara S, Sgaragli G, Cargnelli G, Fusi F. Bova S, et al. Among authors: cima l. Eur J Pharmacol. 2003 Jun 6;470(3):185-91. doi: 10.1016/s0014-2999(03)01797-7. Eur J Pharmacol. 2003. PMID: 12798957

3

Distribution of the vasoconstrictor and vasorelaxant effects of norbormide along the vascular tree of the rat.

Cavalli M, Omiciuolo L, Cargnelli G, Cima L, Hopkins B, Bova S. Cavalli M, et al. Among authors: cima l. Life Sci. 2004 Sep 17;75(18):2157-65. doi: 10.1016/j.lfs.2004.04.022. Life Sci. 2004. PMID: 15325842

4

Norbormide: a calcium entry blocker with selective vasoconstrictor activity in rat peripheral arteries.

Bova S, Cima L, Golovina V, Luciani S, Cargnelli G. Bova S, et al. Among authors: cima l. Cardiovasc Drug Rev. 2001 Fall;19(3):226-33. doi: 10.1111/j.1527-3466.2001.tb00067.x. Cardiovasc Drug Rev. 2001. PMID: 11607040 Review.

5

Synthesis of flavone-2'-carboxylic acid analogues as potential antitumor agents.

Valenti P, Bisi A, Rampa A, Gobbi S, Belluti F, Da Re P, Cima L, Carrara M. Valenti P, et al. Among authors: cima l. Anticancer Drug Des. 1998 Dec;13(8):881-92. Anticancer Drug Des. 1998. PMID: 10335265

6

Vasorelaxant properties of norbormide, a selective vasoconstrictor agent for the rat microvasculature.

Bova S, Trevisi L, Debetto P, Cima L, Furnari M, Luciani S, Padrini R, Cargnelli G. Bova S, et al. Among authors: cima l. Br J Pharmacol. 1996 Mar;117(6):1041-6. doi: 10.1111/j.1476-5381.1996.tb16694.x. Br J Pharmacol. 1996. PMID: 8882594 Free PMC article.

7

Signaling mechanisms for the selective vasoconstrictor effect of norbormide on the rat small arteries.

Bova S, Trevisi L, Cima L, Luciani S, Golovina V, Cargnelli G. Bova S, et al. Among authors: cima l. J Pharmacol Exp Ther. 2001 Feb;296(2):458-63. J Pharmacol Exp Ther. 2001. PMID: 11160631

8

Synthesis and antitumor activity of some analogues of flavone acetic acid.

Valenti P, Fabbri G, Rampa A, Bisi A, Gobbi S, Da Re P, Carrara M, Sgevano A, Cima L. Valenti P, et al. Among authors: cima l. Anticancer Drug Des. 1996 Apr;11(3):243-52. Anticancer Drug Des. 1996. PMID: 8663911

9

Some geiparvarin bioisosteres and homologues: synthesis and biological evaluation against human colon carcinoma cells (LoVo).

Valenti P, Rampa A, Bisi A, Belluti F, Da Re P, Carrara M, Cima L. Valenti P, et al. Among authors: cima l. Anticancer Drug Des. 1997 Mar;12(2):137-44. Anticancer Drug Des. 1997. PMID: 9113068

10

Synthesis, cytotoxicity and SAR of simple geiparvarin analogues.

Valenti P, Rampa A, Recanatini M, Bisi A, Belluti F, Da Re P, Carrara M, Cima L. Valenti P, et al. Among authors: cima l. Anticancer Drug Des. 1997 Sep;12(6):443-51. Anticancer Drug Des. 1997. PMID: 9311554

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters